7Baggers
 Applied Therapeutics stock plunges after FDA meeting on CMT-SORD drug  Investing.com Mon, 29 Sep 2025 13:17:35 GMT
 Applied Therapeutics meets with FDA on potential CMT-SORD drug  Investing.com Mon, 29 Sep 2025 11:29:48 GMT
 Applied Therapeutics Provides Update Following Meeting with FDA  Yahoo Finance Mon, 29 Sep 2025 11:00:00 GMT
 Applied Therapeutics’ Stock Climbs Amid Positive Trial Update  StocksToTrade Sun, 28 Sep 2025 13:44:00 GMT
 Insider Sales At Applied Therapeutics Landed A Good Price  富途牛牛 Sat, 27 Sep 2025 13:18:44 GMT
 Applied Therapeutics Stock Jumps After Positive Trial Update  timothysykes.com Sat, 27 Sep 2025 13:13:00 GMT
 aplt shares surge following update on at-007 trial plans  GuruFocus Fri, 26 Sep 2025 17:39:51 GMT
 Important Notice to Long-Term Shareholders of Applied  GlobeNewswire Tue, 16 Sep 2025 07:56:24 GMT
 News  FinancialContent Mon, 15 Sep 2025 07:00:00 GMT
 silicon valley  FinancialContent Mon, 15 Sep 2025 07:00:00 GMT
 Important Notice to Long-Term Shareholders of Applied  GlobeNewswire Fri, 12 Sep 2025 07:00:00 GMT
 News  FinancialContent Fri, 12 Sep 2025 07:00:00 GMT
 about us  FinancialContent Fri, 12 Sep 2025 07:00:00 GMT
 News  FinancialContent Thu, 11 Sep 2025 07:00:00 GMT
 important notice to long-term shareholders of applied  GlobeNewswire Thu, 11 Sep 2025 07:00:00 GMT
 applied therapeutics reports second quarter 2025 financial results  Investing News Network Wed, 10 Sep 2025 17:28:31 GMT
 published on: 2025-09-03 12:33:27  Newser Wed, 03 Sep 2025 17:33:27 GMT
 published on: 2025-09-02 23:14:31  Newser Wed, 03 Sep 2025 04:14:31 GMT
 applied therapeutics announces new equity offering agreement  The Globe and Mail Sat, 30 Aug 2025 20:30:00 GMT
 applied therapeutics enters $75 million equity sales agreement with cantor fitzgerald  Investing.com Australia Sat, 30 Aug 2025 16:30:02 GMT
 Applied Therapeutics Announces New Equity Offering Agreement  TipRanks Fri, 29 Aug 2025 07:00:00 GMT

Applied Therapeutics Inc
(NASDAQ:APLT) 


Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headqu...

Founded: 2016
CEO: Shoshana Shendelman  
Sector: Health Technology
Industry: Biotechnology

Share this website to your friends